Raynaud's phenomenon. Report of a Meeting of Physicians and Scientists, University College London Medical School, London

The Lancet

Volumn 346, Issue 8970, 1995, Pages 283-290

  Dowd, PaulineM ^a   Goldsmith, PortiaC ^a   Bull, HelenA ^a   Burnstock, Geoffrey ^a   Foreman, JohnC ^a   Marshall, Ian ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTACID AGENT; ANTIBIOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; PROSTACYCLIN; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CASE REPORT; COLD; CYANOSIS; ERYTHEMA; FEMALE; FINGER BLOOD FLOW; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PALLOR; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; TOPICAL DRUG ADMINISTRATION; VASOCONSTRICTION;

EID: 0029094508     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)92169-9     Document Type: Article

References (44)

1. On local asphyxia and symmetrical gangrene of the extremities, 1862, and New research on the nature and treatment of local asphyxia of the extremities, 1872
2. Raynaud's phenomenon
3. Observations upon the reaction of the vessels of the human skin to cold
4. Integration of factors controlling vascular tone. Overview
5. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
6. Cardiovascular action of calcitonin gene-related peptide in humans
7. Occurrence and distribution of neuropeptides in the human skin: an immunocytochemical and immunohistochemical study on normal skin and blister fluid from inflamed skin
8. Calcitonin gene-related peptide-like immunoreactivity in nerve fibres in the human skin: relation to fibres containing substance P-, somatostatin- and vasoactive intestinal peptide-like immunoreactivity
9. Nitric oxide release accounts for the biological activity of endothelium-dependent responses in mammalian blood vessels
10. A novel potent vasoconstrictor peptide produced by endothelial cells
11. The Fifth Heymans Lectures, Ghent. Co-transmission
12. Sympathetic noradrenergic neurons containing dynorphin but not neuropeptide Y innervate small cutaneous blood vessels of guinea-pigs
13. The obligatory role of endothelial cells in the relaxation of arterial smooth by acetylcholine
14. Ultrastructural localization of choline acetyltransferase in vascular endothelial cells in rat brain
15. Localization of vasopressin serotonin and angiotensin II in endothelial cells of the renal and mesenteric arteries
16. Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta
17. Human α-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide
18. Mechanism of vascular relaxation by the calcitonin gene-related peptide
19. 2 from human dermal microvascular endothelial cells
20. Action of vasoactive neuropeptides in microvascular endothelium
21. Serum from patients with Raynaud's phenomenon inhibits prostaglandin release
22. Endothelin-1 in the skin
23. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon
24. Significance of plasma endothelin-1 levels in patients with systemic sclerosis
25. Mechanisms of vasodilatation in the cutaneous microvasculature
26. Nitric oxide synthase isoforms in the human dermal microvasculature
27. On the nature of Raynaud's phenomenon: the role of histamine
28. Digital cutaneous responses to histamine and neuropeptides in Raynaud's phenomenon
29. Peptides and neurogenic inflammation
30. Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon
31. Image analysis quantification of peptide-immunoreactive nerves in the skin of patients with Raynaud's phenomenon
32. Further studies on the action of endothelin-1 on blood flow in human skin
33. Cutaneous nerve depletion and vibration white finger
34. Impaired responses to interadermal injections of histamine and endothelin-1 indicating small nerve fibre dysfunction in vibration white finger
35. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon
36. The effects of topically applied hexyl nicotinate lotion on the cutaneous blood flow in patients with Raynaud's phenomenon
37. 2)
38. Intermittent epoprostanol (prostacyclin) infusion in patients with Raynaud's syndrome: a double blind controlled trial
39. Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue
40. Selective suprasensitivity to calcitonin gene-related peptide in the hands in Raynaud's phenomenon
41. Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon
42. A prospective study of patients with vibration white finger treated with diltiazem
43. NG-nitro-L-arginine methyl ester is an inhibitor of cutaneous vasodilatation due to calcitonin gene-related peptide
44. Acrocyanosis and perniosis: an investigation of cutaneous neuronal and endothelial peptides in digital skin